Axiom Investors’s MetLife MET Stock Holding History

Axiom Investors’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-304,544	Closed	-$14.6M	–	157
2016 Q4	$14.6M	Buy	+304,544	New	+$14M	0.42%	52

Other funds holding MET

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Axiom Investors's MET Position: Q1 2017 in Review

Axiom Investors sold out of MetLife (MET) in Q1 2017, closing a stake of 304,544 shares — an estimated $14.6M sold.

Axiom Investors first reported a position in MET in Q4 2016 and held it in 1 quarter. The position peaked at $14.6M in Q4 2016. 1,046 funds tracked by Wall St. Rank hold MET as of Q1 2017.

Axiom Investors reported no remaining MetLife position as of Q1 2017 after selling out during the quarter.
Axiom Investors sold 304,544 MetLife shares in Q1 2017, an estimated $14.6M.
Axiom Investors first reported a position in MetLife in Q4 2016 and held it in 1 quarter.
Axiom Investors's MetLife position peaked at $14.6M in Q4 2016.
1,046 funds tracked by Wall St. Rank held MetLife as of Q1 2017.

Based on Axiom Investors's 13F filing for Q1 2017, filed 12 May 2017.